title: Pharmacokinetic/pharmacodynamic properties and efficacy/safety of U-500R from randomized clinical studies.
authors.affiliation: a Lilly Diabetes, Lilly USA, LLC , Indianapolis IN , USA.
authors.forename: Cynthia S A
authors.initials: CS
authors.lastname: Brusko
authors.affiliation: a Lilly Diabetes, Lilly USA, LLC , Indianapolis IN , USA.
authors.forename: April D
authors.initials: AD
authors.lastname: Taylor
authors.affiliation: a Lilly Diabetes, Lilly USA, LLC , Indianapolis IN , USA.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Jackson
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D004304:Dosage Forms; D004339:Drug Compounding / Q000379:methods; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D007328:Insulin / Q000493:pharmacokinetics / Q000494:pharmacology; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012196:Review Literature as Topic
chemical_list: D004304:Dosage Forms; D007004:Hypoglycemic Agents; D007328:Insulin